INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2010

A survey of CAM practitioners found wide intravenous vitamin C use, with mostly minor adverse effects reported in 101 of 9,328 patients.

Researchers surveyed attendees at CAM conferences in 2006 and 2008, evaluated manufacturer sales, and reviewed adverse event data regarding intravenous (IV) vitamin C. Of 199 survey respondents, 172 administered IV vitamin C to 11,233 patients in 2006 and 8,876 in 2008, with an average dose of 28 grams every 4 days. Common treatment reasons included infection, cancer, and fatigue. Among 9,328 patients with data, 101 experienced side effects, mostly minor, including lethargy/fatigue (59), mental status change (21), and vein irritation/phlebitis (6). Published cases documented serious events, including 2 deaths in patients with known risk factors; total US patient numbers could not be accurately estimated.

Shows an association, not proof of cause and effect.

Study type
Practitioner survey and adverse event database analysis
Who was studied
199 survey respondents among CAM conference attendees treating 11,233 (2006) and 8,876 (2008) patients
What was measured
Practitioner-reported usage, indications, doses, and adverse events of intravenous vitamin C

THE PAPER

Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.

Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M. PLoS One, 2010.

PubMed 20628650 ↗DOI 10.1371/journal.pone.0011414 ↗

CancerNutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.